Back
Corcept Therapeutics Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
62
CORT
Corcept Therapeutics
Last Price:
$73.55
Seasonality Move:
7.08%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.29 | Sell |
20-day SMA: | 69.89 | Buy |
50-day SMA: | 67.01 | Buy |
200-day SMA: | 54.1 | Buy |
8-day EMA: | 71.09 | Sell |
20-day EMA: | 69.44 | Buy |
50-day EMA: | 55.74 | Buy |
200-day EMA: | 22.69 | Buy |
Corcept Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.67 | Buy |
Relative Strength Index (14 RSI): | 51.26 | Buy |
Chaikin Money Flow: | 536547 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.64 - 72.9) | Buy |
Bollinger Bands (100): | (53.25 - 73.33) | Buy |
Corcept Therapeutics Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 70.84 while CORT 8-day simple moving average is 71.29, which is a Sell signal.
-
The stock price of CORT is 70.84 while Corcept Therapeutics 20-day SMA is 69.89, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 67.01 while CORT share price is 70.84, making it a Buy technically.
-
CORT stock price is 70.84 and Corcept Therapeutics 200-day simple moving average is 54.10, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $70.84. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.5B
Price in USD:
70.84
Share Volume:
1.3M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
27.30
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 70.84 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 70.84 while CORT 8-day exponential moving average is 71.09, which is a Sell signal.
-
The stock price of CORT is 70.84 while Corcept Therapeutics 20-day EMA is 69.44, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 55.74 while CORT share price is 70.84, making it a Buy technically.
-
CORT stock price is 70.84 and Corcept Therapeutics 200-day simple moving average is 22.69, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 3.67, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 51.26, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (66.64 - 72.9), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (53.25 - 73.33), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.